Aortic calcification in haemodialysis patients with diabetes mellitus.

نویسندگان

  • Hiromichi Taniwaki
  • Eiji Ishimura
  • Tsutomu Tabata
  • Yoshihiro Tsujimoto
  • Atushi Shioi
  • Tetsuo Shoji
  • Masaaki Inaba
  • Takashi Inoue
  • Yoshiki Nishizawa
چکیده

BACKGROUND Certain metabolic disorders, such as hyperphosphatemia induce vascular calcification in haemodialysis patients; it is unclear, however, whether these disorders contribute to aortic calcification in diabetic haemodialysis patients. This study examined the risk factors of aortic calcification in a large number of haemodialysis patients, and compared risk factors between diabetic and non-diabetic patients. METHODS The subjects were 667 patients on maintenance haemodialysis: 184 with type 2 diabetes and 483 without. Aortic calcification was measured semi-quantitatively using a plain computed tomography image of the abdominal aorta, and an aortic calcification index (ACI) was calculated. RESULTS The ACI of the diabetic subjects was significantly higher than that of those without diabetes (57.3+/-22.1 vs 44.8+/-28.3%, P < 0.0001), although the dialysis vintage of the former was significantly shorter (P < 0.001). Multiple regression analyses showed that diabetes was a significant independent risk factor for increased ACI. Multiple regression analyses, performed separately in diabetics and non-diabetics, revealed that advanced age, higher systolic blood pressure, smoking and longer haemodialysis vintage were common independent risk factors significantly associated with increased ACI in both patient groups (R2 = 0.296, P < 0.0001 for non-diabetics; R2 = 0.193, P < 0.0001 for diabetics). Higher serum phosphate concentration was not significantly associated with increased ACI in diabetic patients (P = 0.429), although it was a significant independent factor in non-diabetic patients (beta = 0.150, P < 0.0005). CONCLUSION Aortic calcification in diabetic haemodialysis patients is more advanced, compared with non-diabetic patients, even with short haemodialysis vintage. Since disorders of mineral metabolism are not significantly associated with aortic calcification in diabetic haemodialysis patients, aortic calcification in these patients could be affected by metabolic abnormalities associated with the diabetic state per se, independent of other confounding factors; and aortic calcification may be advanced even before haemodialysis induction.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients.

BACKGROUND Vascular calcification has detrimental consequences on chronic kidney disease (CKD) patients, yet its pathogenesis is not fully understood. Fibroblast growth factor-23 (FGF-23) is involved in the regulation of mineral metabolism which may in turn affect vascular calcification. Data on the relationship between FGF-23 and peripheral vascular calcification, using conventional radiograph...

متن کامل

Vascular calcification of the aortic arch and peripheral artery in haemodialysis patients with and without diabetes mellitus.

AIM to look for differences in clinical characteristics, and differences in the role of mineral metabolism disorders and inflammation in diabetic and non diabetic patients. METHODS subjects were 127 patients on maintenance haemodialysis: 46 with DM and 81 without. Vascular calcification of the aortic arch and peripheral artery were recorded qualitatively using x-ray of the chest and lower ext...

متن کامل

High Serum Sclerostin Levels Are Associated with a Better Outcome in Haemodialysis Patients.

BACKGROUND Sclerostin is an osteocyte hormone that decreases osteoblastogenesis. Sclerostin may play a key role in osteoporosis and also in vascular calcification (VC). In chronic kidney disease and haemodialysis (HD) patients, serum sclerostin levels are high. AIM To assess the correlation of serum sclerostin levels with VC, bone mineral density (BMD), and survival rate in HD patients. MET...

متن کامل

Vascular calcification in chronic haemodialysis patients.

Vascular calcification in patients with chronic kidney disease was mentioned for the first time in the 19 century when Virchow described the appearance of metastatic calcification in patients with kidney failure. The subject has gained great interest in recent years as many studies described that a high percentage of patients on chronic haemodialysis show vascular calcification, the extent of w...

متن کامل

Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve.

AIMS To determine whether mitral annular calcification and aortic valve calcification, with or without stenosis, are expressions of atherosclerotic disease. METHODS The incidence of atherosclerotic risk factors was analysed in patients with mitral annular calcification and aortic valve calcification and in control patients from a prospective echocardiographic database of 8160 consecutive pati...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

دوره 20 11  شماره 

صفحات  -

تاریخ انتشار 2005